Inhibitors of the protein–protein interaction between phosphorylated p62 and Keap1 attenuate chemoresistance in a human hepatocellular carcinoma cell line

References

• (a) Chitapanarux T, Phornphutkul K. Risk factors for the development of hepatocellular carcinoma in Thailand. JCTH. 2015;3(3):182–188.
   Google Scholar
  (b) Kar P. Risk factors for hepatocellular carcinoma in India. J Clin Exp Hepatol. 2014;4(Suppl 3):S34–S42..
   PubMedGoogle Scholar
  (c) Fujiwara N, Friedman SL, Goossens N, et al. Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine. J Hepatol. 2018;68(3):526–549.
   PubMed Web of Science ®Google Scholar
• Raza A, Sood GK. Hepatocellular carcinoma review: current treatment, and evidence-based medicine. World J Gastroenterol. 2014;20(15):4115–4127.
   PubMed Web of Science ®Google Scholar
• Gong XL, Qin SK. Progress in systemic therapy of advanced hepatocellular carcinoma. World J Gastroenterol. 2016;22(29):6582–6594.
   PubMed Web of Science ®Google Scholar
• Yang S, Liu G. Targeting the Ras/Raf/MEK/ERK pathway in hepatocellular carcinoma. Oncol Lett. 2017;13(3):1041–1047.
   PubMed Web of Science ®Google Scholar
• Liu J, Liu Y, Meng L, et al. Targeting the PD-L1/DNMT1 axis in acquired resistance to sorafenib in human hepatocellular carcinoma. Oncol Rep. 2017;38(2):899–907.
   PubMed Web of Science ®Google Scholar
• Saeki I, Yamasaki T, Maeda M, et al. Treatment strategies for advanced hepatocellular carcinoma: sorafenib vs hepatic arterial infusion chemotherapy. World J Hepatol. 2018;10(9):571–584.
   PubMed Web of Science ®Google Scholar
• Taniguchi K, Yamachika S, He F, et al. p62/SQSTM1 – Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer. FEBS Lett. 2016;590(15):2375–2397.
   PubMed Web of Science ®Google Scholar
• Rogov V, Dötsch V, Johansen T, et al. Interactions between autophagy receptors and ubiquitin-like proteins form the molecular basis for selective autophagy. Mol Cell. 2014;53(2):167–178.
   PubMed Web of Science ®Google Scholar
• Islam MA, Sooro MA, Zhang P. Autophagic regulation of p62 is critical for cancer therapy. IJMS. 2018;19(5):1405.
   Google Scholar
• Komatsu M, Kurokawa H, Waguri S, et al. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol. 2010;12(3):213–223.
   PubMed Web of Science ®Google Scholar
• (a) Prestera T, Talalay P, Alam J, et al. Parallel induction of heme oxygenase-1 and chemoprotective phase 2 enzymes by electrophiles and antioxidants: regulation by upstream antioxidant-responsive elements (ARE). Mol Med. 1995;1(7):827–837.
   PubMed Web of Science ®Google Scholar
  (b) Wild AC, Moinova HR, Mulcahy RT. Regulation of γ-glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2. J Biol Chem. 1999;274(47):33627–33636.
   PubMed Web of Science ®Google Scholar
  (c) Yates MS, Tran QT, Dolan PM, et al. Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice. Carcinogenesis. 2009;30(6):1024–1031.
   PubMed Web of Science ®Google Scholar
  (d) Mitsuishi Y, Taguchi K, Kawatani Y, et al. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell. 2012;22(1):66–79.
   PubMed Web of Science ®Google Scholar
• McMahon M, Itoh K, Yamamoto M, et al. Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J Biol Chem. 2003;278(24):21592–21600.
   PubMed Web of Science ®Google Scholar
• Zhang DD, Hannink M. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol Cell Biol. 2003;23(22):8137–8151.
   PubMed Web of Science ®Google Scholar
• Pallesen JS, Tran KT, Bach A. Non-covalent small-molecule kelch-like ECH-associated Protein 1-nuclear factor erythroid 2-related Factor 2 (Keap1-Nrf2) inhibitors and their potential for targeting central nervous system diseases. J Med Chem. 2018;61(18):8088–8103.
   PubMed Web of Science ®Google Scholar
• Ichimura Y, Waguri S, Sou YS, et al. Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy. Mol Cell. 2013;51(5):618–631.
   PubMed Web of Science ®Google Scholar
• Saito T, Ichimura Y, Taguchi K, et al. p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming. Nat Commun. 2016;7(1):12030.
   PubMed Web of Science ®Google Scholar
• Yasuda D, Nakajima M, Yuasa A, et al. Synthesis of Keap1-phosphorylated p62 and Keap1-Nrf2 protein-protein interaction inhibitors and their inhibitory activity. Bioorg Med Chem Lett. 2016;26(24):5956–5959.
   PubMed Web of Science ®Google Scholar
• Liu P, Du Y, Song L, et al. Novel, potent, selective and cellular active ABC type PTP1B inhibitors containing (methanesulfonyl-phenyl-amino)-acetic acid methyl ester phosphotyrosine mimetic. Bioorg Med Chem. 2015;23(21):7079–7088.
   PubMed Web of Science ®Google Scholar
• Xu X, Wang X, Zavalij PY, et al. Straightforward access to the [3.2.2]nonatriene structural framework via intramolecular Cyclopropenation/Buchner reaction/cope rearrangement cascade. Org Lett. 2015;17(4):790–793.
   PubMed Web of Science ®Google Scholar
• Nishimura K, Tsuchiya Y, Okamoto H, et al. Identification of chemoresistant factors by protein expression analysis with iTRAQ for head and neck carcinoma. Br J Cancer. 2014;111(4):799–806.
   PubMed Web of Science ®Google Scholar
• Yang WS, Stockwell BR. Ferroptosis: death by lipid peroxidation. Trends Cell Biol. 2016;26(3):165–176.
   PubMed Web of Science ®Google Scholar
• Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060–1072.
   PubMed Web of Science ®Google Scholar
• Xie Y, Hou W, Song X, et al. Ferroptosis: process and function. Cell Death Differ. 2016;23(3):369–379.
   PubMed Web of Science ®Google Scholar
• Yu H, Guo P, Xie X, et al. Ferroptosis, a new form of cell death, and its relationships with tumourous diseases. J Cell Mol Med. 2017;21(4):648–657.
   PubMed Web of Science ®Google Scholar
• Sun X, Ou Z, Chen R, et al. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology. 2016;63(1):173–184.
   PubMed Web of Science ®Google Scholar